arrow
J

Jieming Zhang

sun yat-sen memorial hospital
H指数:9
被引数:619

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

与含高剂量甲氨蝶呤方案相比,足叶乙苷基化疗药物表现出显著降低的毒性,且疗效相当。

BLOOD
IF23.1
2024-11-050
PRE
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study

奥列拉布替尼-布鲁顿酪氨酸激酶抑制剂方案治疗中枢神经系统淋巴瘤的回顾性研究

2022-02-0921
PRE
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

以福莫司汀为基础的治疗与利妥昔单抗联合作为一线诱导化疗,然后进行WBRT治疗新诊断的原发性中枢神经系统淋巴瘤: 一项前瞻性II期试验

2021-10-121
OAAI